Excalibur Group Holdings Overview
- Investor Type
-
Strategic Acquirer
- Status
-
Inactive
- Professionals
-
3
- Investments
-
59
- Exits
-
35
Excalibur Group Holdings General Information
Company Description
Excalibur Group Holdings was a venture capital firm based in London, United Kingdom. The firm was a link between research, development, production, commercialization, supply and distribution of drugs, devices, diagnostics and facilities with individual and institutional investors, equity and debt markets, start-up and expansion capital, strategic advice and ultimately trade sale or flotation. It primarily seeks to invest in the biotechnology, healthcare, and life science sectors.
Business Details
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- Berkley Square House, Berkeley Square, Mayfair
- London W1J 6BD
- England, United Kingdom
Excalibur Group Holdings Investments & Acquisitions (59)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| DestinationSkin | 14-May-2010 | Secondary Transaction - Private | Clinics/Outpatient Services | Generating Revenue | ||
| Celsis International | 09-Oct-2009 | Other Devices and Supplies | Generating Revenue | |||
| Cambridge Clinical Laboratories | 17-Mar-2009 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Selah Genomics | 17-Mar-2009 | Biotechnology | Out of Business | |||
| York Pharma | 01-Oct-2008 | Distributors (Healthcare) | Out of Business | |||
| Merchant Venture Investments | 09-Apr-2008 | Other Capital Markets/Institutions | Profitable | |||
| NeoGen | 01-Dec-2007 | Other Devices and Supplies | Generating Revenue | |||
| De Novo Pharmaceuticals | 31-Dec-2006 | Drug Discovery | Generating Revenue | |||
| Gentiae | 27-Dec-2006 | Later Stage VC | Laboratory Services (Healthcare) | Out of Business | ||
| Neurotech | 16-Nov-2006 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
Excalibur Group Holdings Exits (35)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| De Novo Pharmaceuticals | 01-Apr-2021 | Secondary Transaction - Private | |
| Precision Cellular Storage | 01-Mar-2021 | ||
| NeoGen | 01-Sep-2020 | ||
| DestinationSkin | 17-May-2019 | ||
| TME Pharma | 30-Sep-2016 | ||
| Plethora Solutions Holdings | 04-Feb-2016 | ||
| Celsis International | 24-Jul-2015 | ||
| Cambridge Clinical Laboratories | 28-May-2014 | ||
| Celsis In Vitro | 28-Jun-2013 | Buyout/LBO | |
| NeoGen | 16-Mar-2012 | Buyout/LBO |
Excalibur Group Holdings Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Excalibur Group Holdings FAQs
-
What is Excalibur Group Holdings?
Excalibur Group Holdings was a venture capital firm based in London, United Kingdom.
-
When was Excalibur Group Holdings founded?
Excalibur Group Holdings was founded in 1996.
-
Where is Excalibur Group Holdings headquartered?
Excalibur Group Holdings is headquartered in London, United Kingdom.
-
How many investments has Excalibur Group Holdings made?
Excalibur Group Holdings has made 59 investments.
-
What has Excalibur Group Holdings invested in?
Excalibur Group Holdings has made numerous investments in companies like DestinationSkin, Celsis International, and Cambridge Clinical Laboratories within the Clinics/Outpatient Services, Devices and Supplies, and Laboratory Services (Healthcare) industries.
-
What has Excalibur Group Holdings invested in recently?
Excalibur Group Holdings's latest investment was on 14-May-2010 in DestinationSkin, a company within the Clinics/Outpatient Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
